Assessment of Usefulness of Next Generation Sequencing in Cancer Identification and Treatment

Mr Chua Kheng Wee Louis asked the Minister for Health (a) what is the prevalence of next generation sequencing (NGS), a technology for determining the sequence of DNA or RNA to study genetic variation associated with diseases or other biological phenomena, in Singapore; (b) what is the Government's assessment of the usefulness of NGS in cancer identification and treatment; and (c) whether the Government intends to provide guidelines on the use of NGS in Singapore.

Mr Ong Ye Kung: This question has been addressed in written reply to Parliamentary Question No 35 in the 7 January 2025 Sitting. [Please refer to "Timeline for Developing Guidelines on Next Generation Sequencing and Potential of Sequencing as Screening Tool", Official Report, 7 January 2025, Vol 95, Issue 148, Written Answers to Questions section.]